Monoclonal Antibodies For Metastatic Colon Or Rectal Cancer (Cetuximab And/Or Panitumumab)

Valstybine ligoniu kasa prie Sveikatos apsaugos ministerijos Lithuania has Released a tender for Monoclonal Antibodies For Metastatic Colon Or Rectal Cancer (Cetuximab And/Or Panitumumab) in Pharmaceuticals. The tender was released on Jul 23, 2024.

Country - Lithuania

Summary - Monoclonal Antibodies For Metastatic Colon Or Rectal Cancer (Cetuximab And/Or Panitumumab)

Deadline - login to view

MT reference number - 19184477

Product classification - Antineoplastic agents

Organization Details:

  Address - Lithuania

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 19184477

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The procuring organization intends to purchase - monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab) (hereinafter - medicinal product/product).The purchase object is divided into 2 parts:Part 1 of the procurement object. Only one medicinal product, Cetuximab or Panitumumab, will be purchased for the treatment of new patients (specified in the Technical Specification Table of Annex 2 of SS: Subsection 1.1 or Subsection 1.2); Part 2 of the procurement object. For the continuous treatment of patients, the drug Panitumumab will be purchased (specified in point 2 of the "Technical specification table" of Appendix 2 of SS).local

Mt Ref Id - 19184477

Deadline - Aug 23, 2024

Share

Similar Tenders :